Free Trial

KindlyMD, Inc. (NASDAQ:NAKA) Short Interest Update

KindlyMD logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest fell by 14.0% in March to 17,793,290 shares, representing about 4.3% of the company's stock sold short and a days-to-cover ratio of 3.4.
  • Analyst sentiment is mixed—two Buys, one Hold and one Sell—yielding an average rating of Hold and an average target price of $4.25, while B. Riley cut its target to $0.50 and Weiss Ratings reiterated a Sell.
  • Shares trade around $0.21 (a 52‑week low) with a market cap near $93.9M and an extremely high beta (31.40), reflecting pronounced volatility against a 52‑week high of $34.77.
  • Five stocks we like better than KindlyMD.

KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 17,793,290 shares, a decrease of 14.0% from the February 26th total of 20,681,566 shares. Currently, 4.3% of the company's stock are sold short. Based on an average trading volume of 5,244,666 shares, the days-to-cover ratio is currently 3.4 days.

Institutional Trading of KindlyMD

Hedge funds have recently added to or reduced their stakes in the business. Sagespring Wealth Partners LLC bought a new position in KindlyMD in the 4th quarter worth approximately $28,000. SG Americas Securities LLC bought a new stake in shares of KindlyMD in the fourth quarter valued at approximately $61,000. Virtu Financial LLC acquired a new stake in shares of KindlyMD in the fourth quarter worth $151,000. J. Derek Lewis & Associates Inc. bought a new position in KindlyMD during the fourth quarter worth $167,000. Finally, Truist Financial Corp bought a new position in KindlyMD during the fourth quarter worth $176,000.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on NAKA shares. Weiss Ratings restated a "sell (e+)" rating on shares of KindlyMD in a report on Friday. B. Riley Financial lowered their price target on KindlyMD from $1.00 to $0.50 and set a "buy" rating on the stock in a report on Monday, February 23rd. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $4.25.

View Our Latest Stock Analysis on KindlyMD

KindlyMD Stock Up 1.6%

NAKA stock traded up $0.00 during mid-day trading on Tuesday, reaching $0.21. 970,278 shares of the stock traded hands, compared to its average volume of 5,244,755. KindlyMD has a 52 week low of $0.21 and a 52 week high of $34.77. The business has a 50-day moving average of $0.29 and a two-hundred day moving average of $0.57. The firm has a market capitalization of $93.86 million, a PE ratio of -0.19 and a beta of 31.40.

About KindlyMD

(Get Free Report)

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in KindlyMD Right Now?

Before you consider KindlyMD, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KindlyMD wasn't on the list.

While KindlyMD currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines